Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: Effect of chronic hypoxia in the rat

British Journal of Pharmacology

Volumn 123, Issue 8, 1998, Pages 1621-1630

  McCulloch, Kirsty M ^a,b   Docherty, Cheryl ^a   MacLean, Margaret R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Endothelin receptors; Pulmonary arteries; Pulmonary hypertension; SB 209670

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; RESISTANCE BLOOD VESSEL;

ANIMALS; ANOXIA; CHRONIC DISEASE; ENDOTHELIN-1; ENDOTHELIN-3; HUMANS; INDANS; MALE; MUSCLE CONTRACTION; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0031920655     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701785     Document Type: Article

References (44)

1. ADNOT, S., RAFFESTIN, B., EDDAHIBI, S., BRAQUET, P. & CHARBRIER, P.E. (1991). Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest., 87, 155-170.
2. ARAI, I.H., HORI, S., ARAMORI, I., OHKUBO, H. & NAKINISHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 731-732.
3. BARNES, P.J. & LIU, S.F. (1995). Regulation of pulmonary vascular tone. Pharmacol. Rev., 47, 87-131.
4. A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am. J. Physiol., 266, H1327-H1331.
5. CHIEN, S.J., CHEN, Y.F., MENG, Q.C., DURAND, J., DICARLO, V.S. & OPARIL, S. (1995). Endothelin receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol., 79, 2122-2131.
6. A antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodelling in Spraque-Dawley rats. J. Cardiovasc. Pharmacol., 29, 713-725.
7. CLOZEL, M., BREU, V., GRAY, G., KALINA, B., LÖFFLER, B., BURRI, K., CASSAL, J., HIRTH, G., MÜLLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterisation of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
8. A-receptor antagonist prevents and reverses chronically hypoxia-induced pulmonary hypertension in the rat. Am. J. Physiol. (Lung Cell. Mol. Physiol.), 13, L690-697.
9. B receptors in rabbit pulmonary resistance arteries: effect of left ventricular dysfunction. J. Pharmacol. Exp. Ther., (in press).
10. DOUGLAS, S.A., BECK, G.R., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995). Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein. Br. J. Pharmacol., 114, 1529-1540.
11. ELSHOURBAGY, N.A., ADAMOU, J.E., GAGNON, A.W., WU, H.L., PULLEN, M. & NAMBI, P. (1996). Molecular characterisation of a novel human endothelin receptor splice variant. J. Biol. Chem., 271, 25300-25307.
12. ELTON, T.S., OPARIL, S., TAYLOR, G.R., HICKS, P.H., YANG, R.-H., JIN, H. & CHEN, Y.F. (1992). Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am. J. Physiol., 32, R1260-R1264.
13. FUKURODA, T., OZAKI, S., IHARA, M., ISHIKAWA, K., YANO, M. & NISHIKIBE, M. (1994). Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Br. J. Pharmacol., 113, 336-338.
14. GODFRAIND, T. (1993). Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br. J. Pharmacol., 110, 1201-1205.
15. HAY, D.W.P. & LUTTMANN, M.A. (1997). Nonpeptide endothelin antagonists. IX. Characterisation of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists. J. Pharmacol. Exp. Ther., 280, 959-965.
16. B) receptors in rabbit isolated pulmonary artery and bronchus. Br. J. Pharmacol., 118, 1209-1217.
17. HERGET, J., SUGGETT, A.J., LEACH, E. & BARER, G.R. (1978). Resolution of pulmonary hypertension and other features induced by chronical hypoxia in rats during complete and intermittent normoxia. Thorax, 33, 468-473.
18. HUNTER, C., BARER, G.R. SHAW, J.W. & CLEGG, E.J. (1974). Growth of the heart and lungs in hypoxic rodents: A model of human hypoxic disease. Clin. Sci. Mol. Med., 46, 375-391.
19. ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKORODA, T., FUKAMI, T., OZAKI, S., NAGASE, T., NISHIKIBE, M. & YANO, M. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A., 91, 4892-4896.
20. JANAKIDEVI, K., FISHER, M.A., DELVECCHIO, P.J., TIRUPPATHI, C., FIGGE, J. & MALIK, A.B. (1992). Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am. J. Physiol., 263, C1295-C1301.
21. KARNE, S., JAYAWIRCKREME, C.K. & LERNER, M.R. (1993). Cloning and characterisation of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem., 268, 19126-19133.
22. B receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction. Biochem. Biophys. Res. Commun., 196, 209-215.
23. LEACH, E., HOWARD, P. & BARER, G.R. (1977). Resolution of hypoxic changes in the heart and pulmonary arterioles of rats during intermittent correction of hypoxia. Clin. Sci. Mol. Med., 52, 153-162.
24. LI, H., ELTON, T.S., CHEN, F. & OPARIL, S. (1994). Increased endothelin receptor gene expression in hypoxic rat lung. Am. J. Physiol., 266, L553-L560.
25. MACLEAN, M.R. & MCCULLOCH, K.M. (1998). Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronical hypoxia. Br. J. Pharmacol., 123, 991-999.
26. B-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J. Cardiovasc. Pharmacol., 23, 838-845.
27. MACLEAN, M.R., MCCULLOCH, K.M. & BAIRD, M. (1995). Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6c and on inherent tone in rat pulmonary arteries. J. Cardiovasc. Pharmacol., 26, 822-830.
28. MACLEAN, M.R., SWEENEY, G., BAIRD, M., MCCULLOCH, K.M., HOUSLAY, M. & MORECROFT, I. (1996). 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br. J. Pharmacol., 119, 1125-1130.
29. MANSOOR, A.M., HONDA, M., SAIDA, K., ISHINAGA, Y., KURAMOCHI, T., MAEDA, A., TAKABATAKE, T. & MITSUI, Y. (1995). Endothelin induced collagen remodelling in experimental pulmonary hypertension. Biochem. Biophys. Res. Commun., 215, 981-986.
30. MASAKI, J., KIMURA, S., YANAGISAWA, M. & GOTO, K. (1991). Molecular and cellular mechanisms of endothelin regulation. Implications for vascular function. Circulation, 84, 1457-1468.
31. B receptors mediate contraction of human pulmonary resistance arteries. Br. J. Pharmacol., 119, 1125-1130.
32. B receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J. Cardiovasc. Pharmacol., 26, S169-S176.
33. OHLSTEIN, E.H., BECK, G.R., DOUGLAS, S.A., NAMBI, P., LAGO, A., GLEASON, J.G., RUFFOLO, R.R., FEUERSTEIN, G. & ELLIOTT, J.D. (1994a). Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J. Pharmacol. Exp. Ther., 271, 762-768.
34. OHLSTEIN, E.H., NAMBI, P., DOUGLAS, S.A., EDWARDS, R.M., GELLAI, M., LAGO, A., LEBER, J.D., COUSINS, R.D., GAO, A., FRAZEE, J.S., PEISHOFF, C.E., BEAN, J.W., EGGLESTON, D.S., ELSHOURBAGY, N.A., KUMAR, C., LEE, J.A., YUE, T., LOUDEN, C., BROOKS, D.P., WEINSTOCK, J., FEUERSTEIN, G., POSTE, G., RUFFOLO, R.R., GLEASON, J.G. & ELLIOTT, J.D. (1994b). SB 209670, a rationally designed potent non-peptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 8052-8056.
35. A receptor-mediated phenomenon. Br. J. Pharmacol., 118, 191-197.
36. PERRAULT, T. & BARIBEAU, J. (1995). Characterisation of endothelin receptors in newborn piglet lung. Am. J. Physiol., 268, L607-L614.
37. RUBANYI, G.M. & POLOKOFF, M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol. Rev., 46, 325-415.
38. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. & MASAKI, T. (1990). Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature, 348, 732-735.
39. SHYAMALA, V., MOULTHROP, T.H.M., STRATTONTHOMAS, J. & TEKAMPOLSON, P. (1994). 2 distinct human endothelin-B receptors generated by alternative spicing from a single gene. Cell. Mol. Biol. Res., 40, 285-296
40. A receptor antagonist. J. Cardiovasc. Pharmacol., 264, 1040-1046.
41. A antagonist 5-(dimethylamino)-N-(3-4-dimethyl-5-isozazolyl)-1-naphthalenesulfonamide. J. Med. Chem., 37, 329-331.
42. STEWART, D.J., LEVY, R.D., CERNACEK, P. & LANGLEBEN, D. (1991). Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann. Intern. Med., 114, 464-469.
43. B. Am. J. Physiol., 267, C1130-C1135.
44. A receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol., 9, 429-433.